Hiscox Ltd Share Price London S.E.
Equities
HSX
BMG4593F1041
Property & Casualty Insurance
End-of-day quote
Other stock markets
|
||
- GBP | - |
08/05 | UBS raises Centrica to 'buy' from 'neutral | AN |
07/05 | AstraZeneca target raised; Antofagasta lowered | AN |
Sales 2024 * | 3.89B 4.95B 412B | Sales 2025 * | 4.27B 5.43B 452B | Capitalization | 4B 5.09B 424B |
---|---|---|---|---|---|
Net income 2024 * | 469M 597M 49.67B | Net income 2025 * | 504M 641M 53.38B | EV / Sales 2024 * | 1.03 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 0.94 x |
P/E ratio 2024 * |
8.58
x | P/E ratio 2025 * |
7.87
x | Employees | - |
Yield 2024 * |
2.77% | Yield 2025 * |
3.07% | Free-Float | 97.42% |
Latest transcript on Hiscox Ltd
Managers | Title | Age | Since |
---|---|---|---|
Hamayou Hussain
CEO | Chief Executive Officer | 51 | 22/16/22 |
Paul Cooper
DFI | Director of Finance/CFO | 52 | 12/22/12 |
Stéphane Flaquet
COO | Chief Operating Officer | - | 01/10/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 60 | 16/17/16 | |
Anne MacDonald
BRD | Director/Board Member | 68 | 20/15/20 |
Colin Keogh
BRD | Director/Board Member | 69 | 19/15/19 |
1st Jan change | Capi. | |
---|---|---|
+46.81% | 63.84B | |
+16.47% | 52.22B | |
+13.68% | 49.52B | |
+18.71% | 44.39B | |
+38.28% | 38.01B | |
+70.28% | 32.08B | |
+11.60% | 29.76B | |
+26.86% | 25.61B | |
+2.63% | 22.21B |
- Stock Market
- Equities
- HSX Stock
- HSX Stock